News

The study indicates that in animals treated with PLX cells, there were differences to the control groups in the following parameters: improvement in sensory and motor deficits, reduction

The MermaiHD study met the primary endpoint to show an effect on voluntary motor function. In addition, data from the 437 huntington patients, who participated in the study

The company said that the purchase price is $110m cash subject to a customary working capital adjustment. The acquisition is expected to close in the first quarter of

Dr Nielsen most recently served as executive vice president of pharmaceuticals for URLMutual Pharmaceutical, where he lead new product development and licensing activities for both products and drug

The company said that the patent issuance opens the door for sales and distribution into Mexico, and is expected to accelerate HealthSport’s move into the international marketplace. The

The company said that the Phase 3 X-PECT (Xeloda + Perifosine Evaluation in Colorectal cancer Treatment) trial will be a randomised (1:1), double-blind trial comparing the efficacy and

Algeta’s lead product Alpharadin (based on radium-223) is a highly targeted alpha-pharmaceutical under clinical evaluation, to improve survival in patients with bone metastases from advanced cancer. Its localized

The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds, using optimised microbial production strains taking plant derived raw materials as starting

The company said that once the review is completed, they intend to move forward a fully-compliant 510(k) submission. The submission will be based on the regulatory strategy and